ArticleClinical Medicine Insights. Oncology2024

Efficacy and Safety of Paclitaxel-Based PD-1/PD-L1 Immunotherapies for Triple-Negative Breast Cancer: A Systematic Review and Network Meta-Analysis.

Youran Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.